Open Access

Efficacy of the CV‑MED regimen in treating extramedullary involvement of multiple myeloma: A case report

  • Authors:
    • Jinjie Gao
    • Fei Dong
    • Xu Zhang
    • Hongmei Jing
  • View Affiliations

  • Published online on: October 14, 2024     https://doi.org/10.3892/ol.2024.14745
  • Article Number: 612
  • Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Extramedullary progression of multiple myeloma (MM) is commonly associated with a poor prognosis. However, optimal management strategies have not yet been established for the treatment of extramedullary involvement in MM. The present study reports the case of a 59‑year‑old female patient with MM who experienced extramedullary progression after two cycles of first‑line VRD (bortezomib, lenalidomide and dexamethasone) therapy. The patient achieved remission of the extramedullary lesion following treatment with an innovative CV‑MED regimen, which includes chidamide, bortezomib, mitoxantrone hydrochloride liposome, etoposide and dexamethasone. Subsequently, the patient underwent autologous hematopoietic stem cell harvesting and maintenance therapy, and remains in a progression‑free survival state. The present case suggests that a chemotherapy regimen incorporating mitoxantrone hydrochloride liposomes, chidamide and bortezomib could be a promising treatment strategy for managing extramedullary involvement in MM.

Related Articles

Journal Cover

December-2024
Volume 28 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gao J, Dong F, Zhang X and Jing H: Efficacy of the CV‑MED regimen in treating extramedullary involvement of multiple myeloma: A case report. Oncol Lett 28: 612, 2024.
APA
Gao, J., Dong, F., Zhang, X., & Jing, H. (2024). Efficacy of the CV‑MED regimen in treating extramedullary involvement of multiple myeloma: A case report. Oncology Letters, 28, 612. https://doi.org/10.3892/ol.2024.14745
MLA
Gao, J., Dong, F., Zhang, X., Jing, H."Efficacy of the CV‑MED regimen in treating extramedullary involvement of multiple myeloma: A case report". Oncology Letters 28.6 (2024): 612.
Chicago
Gao, J., Dong, F., Zhang, X., Jing, H."Efficacy of the CV‑MED regimen in treating extramedullary involvement of multiple myeloma: A case report". Oncology Letters 28, no. 6 (2024): 612. https://doi.org/10.3892/ol.2024.14745